After making its Wall Street debut earlier this year, cell therapy biotech firm Arcellx has signed a lease to expand its footprint in one of the top biotech clusters in the country.
After making its Wall Street debut earlier this year, cell therapy biotech firm Arcellx has signed a lease to expand its footprint in one of the top biotech clusters in the country.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
800 King Farm Blvd, Rockville, MD
Executive Managing Director, Cushman & Wakefield
Executive Director, Cushman & Wakefield
Vice President, Scheer Partners
Principal & Senior Vice President, Scheer Partners
Managing Director, Cushman & Wakefield